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ABSTRACT Filamins are actin binding proteins that contribute to cytoskeletal integrity and biochemical scaffolds during mech-
anochemical signal transductions. Structurally, human ﬁlamins are dimers composed of an actin-binding domain with 24 immu-
noglobulin (Ig)-like repeats. In this study, we focus on the recently solved high-resolution crystal structure of Ig-like repeats 19–21
of ﬁlamin-A (IgFLNa-R19–R21). IgFLNa-R19–21 is of marked importance because it contains the binding site for integrins and
facilitates the dynamic ability of ﬁlamin-A to communicate with the extracellular environment. However, the structure of ﬁlamin-A
shows an interesting domain arrangement where the integrin binding site on IgFLNa-R21 is hindered sterically by IgFLNa-R20.
Thus, a number of hypotheses on the regulation of ﬁlamin-A exist. Using molecular dynamics simulations we evaluated the
effects of two primary regulators of ﬁlamin-A, force and phosphorylation. We ﬁnd that a tensile force of 40 pN is sufﬁcient to initiate
the partial removal of the autoinhibition on the integrin binding site of IgFLNa-R21. Force coupled to phosphorylation at Ser2152,
however, affords complete dissociation of autoinhibition with a decreased force requirement. Phosphorylation seems to decrease
the threshold for removing the IgFLNa-R20 b-strand inhibitor within 300 ps with 40 pN tensile force. Furthermore, the molecular
dynamic trajectories illustrate phosphorylation of Ser2152 without force is insufﬁcient to remove autoinhibition. We believe the
results of this study implicate ﬁlamin-A as a tunable mechanosensor, where its sensitivity can be modulated by the degree of
phosphorylation.INTRODUCTION
The dynamic nature of the cytoskeleton is due, in part, to the
multitudes of reorganizing proteins that alter the geometry of
the cytoskeletal network. Consequentially, as the geometry
of the cytoskeleton is altered, so are the physical characteris-
tics of the cell such as, shape, position, stiffness, and even
metabolism (1,2). It was once believed that cells lacked
major organization and that their cytosol was likened to
a soup of chemicals. However, recent evidence is surfacing
that illustrate a precise localization of signal transduction and
intracellular biochemistry. This is made possible by the
precise organization of cellular factors that are either directly
or indirectly anchored to the cytoskeleton. In addition to this
scaffolding role that the cytoskeleton plays during signaling
and metabolism, the cytoskeleton itself can also serve as a
transducer of mechanical stimuli through cascades involving
second messengers that are actin-associated proteins (3–6).
Of these actin-binding proteins, filamin plays an important
dual role in regulating the dynamic integrity of the actin
cytoskeleton and in cellular mechanotransduction. Filamins
contain the unique capacity to orient the actin filaments
orthogonally resulting in the formation of a 90 meshlike
F-actin network (7). Filamins function as molecular dimers,
and are classically described as functioning in formation of
lamellipodia, but are also localized to the cortical actin
network to function as a scaffold for a trafficking transmem-
brane receptors, signaling and adaptor proteins (1,2,7). In
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can be degraded by proteolysis yielding products that may
function as signaling molecules, integrating nuclear and
cytosolic pathways (8–10).
Of the three existing homologs, filamin-A is most abun-
dant and widely expressed (7,11) and is essential to normal
human development (12,13). The diversity in phenotypes
associated with different filamin mutations shows that fila-
mins carry out a variety of essential functions and the current
evidence suggests that in many cases specific disease pheno-
types will result from disruption of specific interactions
between IgFLNa-R domains and their binding partners (14).
Each human filamin-A (FLNa) monomer is a 240–280 kDa
actin cross-linking protein composed of an N-terminal actin-
binding domain, a rod domain of 24 immunoglobulin (Ig)-like
repeats (IgFLNa-R) (Fig. 1A) (7,15,16). Electron microscopy
and sequence analysis studies suggest a v-shaped structure for
filamin due to hinges between IgFLNa-R15 and -R16 and
IgFLNa-R23 and -R24 (17,18). More recently, however,
IgFLNa-R domain 19–21 (IgFLNa-R19–21) was crystal-
lized, and an unexpected domain arrangement was discovered
that illustrated IgFLNa-R20 as partially unfolded and brings
IgFLNa-R21 into close proximity to IgLFNa-R19 (14). The
N-terminus of IgFLNa-R20 forms a b-strand that associates
with IgFLNa-R21, which has been identified previously as a
major binding site for integrin adhesion receptors (14,19–21)
(Fig. 1 B). This b-strand sterically hinders the binding of
IgFLNa-R21 to integrin adhesion receptors (14).
The major role of filamin-A and integrin binding is to regu-
late cell spreading and survival (22). Other research has
shown that filamin-A may modulate cell sensitivity to force
and mechanoprotection (23,24). Integrin ab-heterodimers
doi: 10.1016/j.bpj.2009.08.059
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environment to the actin cytoskeleton (5,8). Thus, the fila-
min-integrin complexes could provide a mechanical and
biochemical link through which the actin cytoskeleton could
respond to external cues. Filamin-A binds integrin at IgFLNa-
R21, and leads to the transduction of mechanical stimuli from
extracellular domain to intracellular domain through focal
adhesions (25).
The structure of IgFLNa-R21 is a b-sandwich composed
of two b-sheets. The integrin b7 cytoplasmic domain binds
to the CD face of the IgFLNa-R21 (26). The CD face is
the integrin-binding site formed by the two b-strands that
were identified by a previous study (26). In our model, the
FIGURE 1 (A) Illustration of the structure of a human filamin-A. The
figure also illustrates how filamins crosslinks actin filaments into orthogonal
networks in cortical cytoplasm. At the N-terminus is the actin binding
domain, and is followed by the Ig-like repeats (IgFLNA-R1–IgFLNA-
R24). This study focuses on the binding of integrin with filamin-A at rod
repeat 21. (B) The structure of IgFLNa-R19–21 with Ser-2152 phosphoryla-
tion illustrated (circled). IgFLNa-R19 is on the left; IgFLNa-R20 is on the
right; IgFLNa-R21 is in the middle. The phosphoSer2152 residue was shown
circled. The protein structure was obtained through Protein Data Bank
(PDB ID: 2JS3) (14), and the Ser2152 side chain was modified through
CHARMm software. (C) A depiction of how the tension force was applied
to the unphosphorylated rod domain repeats 19–21, Model 4. In these simu-
lations, the C-terminus of repeat 21 was fixed, which is represented by a gray
bead. In A, force was applied to pull the N-terminus of repeat 19 along the
axis of the rod domain. We also tested the effect of torque as in B. With tor-
que the autoinhibition could be further removed from the integrin bind site of
repeat 21.Biophysical Journal 97(12) 3095–3104CD face corresponds to the two b-strands formed by amino
acid residues 2268–2287. Integrin binding to IgFLNa-R21
can be inhibited by phosphorylation of the integrin tail or
by other integrin tail binding proteins that compete with
filamin (14). NMR and biochemical analyses indicate that
the IgFLNa-R20-21 domain pair inhibits integrin b-tail
binding and mutations perturbing the IgFLNa-R20-21 inter-
action enhance integrin binding (27).
It has been suggested that disrupting this IgFLNa-R20 and
IgFLNa-R21 interaction will reveal the binding site for integ-
rin on IgFLNa-R21 and facilitate the binding to integrin.
Three methods of regulation have been proposed, mechan-
ical force, phosphorylation of the inhibitory domain on
Ser2152 residue, and alternative splicing leading to splico-
zymes lacking the inhibitory peptide region (14,19–21). In
addition, these three hypotheses may be seemingly interre-
lated. For example, mechanical signals are abundant in cell
biology and are intimately linked with biochemical signaling
pathways (28,29).
The objective of this study is to test the hypotheses leading
to the activation and integrin binding of filamin-A. It has
been illustrated previously that lack of the inhibitory region
through alternative splicing increases the interaction of
filamin with integrin (11,30). The inhibitory domain of
IgFLNa-R20 regulates the filamin-A integrin-binding on
IgFLNa-R21. This study focuses on the phosphorylation of
Ser2152 and the applied mechanical force, which are two
important potential factors involved in regulating integrin
binding. Functionally, forces applied to this region can phys-
ically dissociate the inhibitory domain of IgFLNa-R20, but
this may be independent and exclusive of phosphorylation
at this same site. Alternatively, the two mechanisms, phos-
phorylation and mechanical force, may work synergistically,
and these questions motivate our experimental endeavor.
MATERIALS AND METHODS
Crystal structure of IgFLNa-R19–21 was obtained through Protein Data
Bank (PDB ID: 2JS3) (14). A complete filamin molecule, including all 24
rod domain IgFLNa-Rs has not yet been crystallized successfully. Visual
molecular dynamic (MD) software was used to explore the secondary struc-
ture of the protein and for postprocessing of our MD results (31).
The simulated structure corresponds to the amino acid residues 2045–
2329 of the full length filamin-A sequence. The atomistic coordinates for
residues 2163–2170 and 2191–2197 were undetermined in the original pub-
lished IgFLNa-R19–21 structure (14). The missing structure was completed
using structural and sequence alignment methods with SWISS-MODEL-
EXPASY software (14,32–34). The missing residues corresponded to
isolated loop-like regions of IgFLNa-R21.
MD simulations were carried out using software CHARMm version
c32b1 (35,36). CHARMm was also used to model the phosphate group
onto Ser2152 (Fig. 1 B) (36). A switching function with values between
12.0 A˚ and 13.0 A˚ were used to cut off with nonbonding van der Waals
and electrostatic interactions. The total number of atoms within the system
was 4195 and 4199 for unphosphorylated and phosphorylated models,
respectively. The models were linearly heated to 310 K and constant steering
forces of 0–40 pN were applied for 5 ns (37). However, all the noticeable
conformation changes occurred within the first 500 ps. After the 500 ps
Filamin and Integrin Binding 3097time frame, all the models showed stabled conformations as determined
through root mean-square deviation (RMSD) calculations of the a-carbon
backbone. Therefore, we decided to discuss the model within the 500 ps
timescale.
To represent solvent environment, an implicit model was used for solvent-
protein interactions, namely the analytical continuum electrostatics (ACE)
water model available in CHARMm (38). This model approximates the
electrostatic and nonelectrostatic contributions of water molecules to the
effective free energy. Poisson’s equation was used to calculate the electro-
static contribution to the free energy (38). The ACE parameters were set
to 1.0 IEPS (dielectric constant used for the space occupied by the mole-
cule), 80 SEPS (dielectric constant used to approximate solvent), ALPHA
1.3 (Gaussian density distribution that determines atom volume), and sigma
2.5 (hydrophobic contribution scaling value to ACE).
The implicit water model simulates aqueous environment by treating
the water molecules as a continuum dielectric constant while incorporating
the free energy change due to solvation (39). After the implicit models, we
confirmed all our simulations using the explicit model for water representa-
tion as well (40). When a water molecule makes a hydrogen bond (h-bond)
with the protein backbone, its lifetime can be longer than several picosec-
onds (41). This can lead to cooperative dissociation of the backbone
h-bond network. In implicit solvent simulations, even if a h-bond is tempo-
rarily destabilized, it will soon reform because the solvation effect is imple-
mented as smooth energy surface so that the H and O atoms are still in a local
energy well.
The implicit model was always preferred initially because in explicit
models the large number of water molecules yield intractable within reason-
able timeframes. Furthermore, modeling the solvent explicitly is exception-
ally computationally demanding, as the number of atoms can increase at
least an order of magnitude. It was necessary to limit our use of explicit
water simulations as a reference and validation tool only, rather than an
explorative one.
Six simulation models were used to study the effect of tension force and
phosphorylation, and the parameters used are summarized in Table 1. We
simulated all possible combinations of phosphorylation and force. Models
including force are pre-equilibrated, or in other words are continuations of
models 1 and 2. For each simulation, a constant force was applied to the
N-terminal residue on IgFLNa-R19 with the magnitudes of force for each
simulation of Model 3 to 6 were 10,20,30, and 40pN of force. In addition,
each scenario was repeated a minimum of five times to verify the observed
trajectories.
To determine a relevant order of magnitude of tension force to remove
the autoinhibitory strand, a constant velocity model in explicit water box
was run using NAMD. The model was phosphorylated, and the constraints
and direction of pull followed exactly as the models they were represent-
ing (Table 1). The velocity was 0.0002 A˚/ps, and the model was run for
50 ns over a 100 A˚ distance. The resulting force required was ~100 pN.
Therefore, we decided to use 10 pN with 10 pN increment to begin the
experiment.Constraints applied in the MD simulations and
justiﬁcations
Initially, to test for the effect of phosphorylation and forces, only the
C-terminus on IgFLNa-R21 was fixed. However, with only the C-terminus
(Pro2328) fixed, the repeat containing integrin binding capacity, IgFLNa-
R21, would unfold significantly at forces>20 pN (Fig. 2 A). This took place
in both phosphorylated and nonphosphorylated models. Furthermore, the
autoinhibition could not be dissociated before unfolding of IgFLNa-R21,
and IgFLNa-R20 does not refold and approach the b-inhibitor as expected
(see Results). Therefore, more constraints were added to IgFLNa-R21 to
stabilize IgFLNa-R21. We empirically fixed residues on the C-terminal
loop regions to stabilize IgFLNa-R21. Through minimizing these constraints
we were able to identify residues that must be fixed to stabilize IgFLNa-R21
during tension, and the constraints used are summarized in Table 1. Consis-
tently, we found residues Pro2328, Pro2302, and Pro2252 are necessary for
stabilization of IgFLNa-R21 under tension (Fig. S1 in the Supporting
Material). The cis-amide bond formed by proline produces a kink in the
amino acid primary structure and from our analyses seems essential to
maintain the Ig fold of IgFLNa-R21.
These constraints could also represent interactions that may exist in the
full-length protein between the rod domain repeats IgFLNa-R20–21 and
IgFLNa-R22–24. These interactions may stabilize IgFLNa-R20 and 21
when tension force is exerted and prevents significant conformational distor-
tion during tension, preserving the integrin binding capability. Using
multiple constraints also promoted the refolding of IgFLNa-R20, and in
essence provides an interesting mechanistic hypothesis to the stabilization
present once this autoinhibitory region is dissociated.
The direction of the mechanical perturbation was varied to identify the
conformational reaction of the rod domain with torque applied, in addition
to the axial tension (Fig. 1 C (A, red arrow)). After the MD simulation,
the structural trajectories were analyzed to determine the conformational
changes due to applied mechanical perturbations. Each IgFLNa-R is colored
uniquely to clarify the relative movements of the repeats as well as the
changes in structure (Fig. 1 B). The structural trajectories of the b-strand
inhibitor were examined during the course of these simulations.
To assess the integrin binding characteristics of filamin-A, we assumed
that the propensity of filamin to bind to integrin is increased when the
b-strand inhibitor of IgFLNa-R20 has completely dissociated from the
IgFLNa-R21, exposing the integrin binding site. We also consider that reas-
sociation of the partially unfolded IgFLNa-R20 with its b-strand may also
promote the stability of this potentially activated conformation of filamin-A.
RESULTS
In this study, we simulate hypothetical mechanisms of the
activation of filamin-A integrin binding, namely phosphory-
lation of Ser2152 and mechanical force. The goal of theseTABLE 1 Models used in the simulations
Model
Phosphorylation
on Ser2152
Force applied
on IgFLNa-R19
Constraints
(protein residue No.)
Implicit model
system size (atoms)
Explicit model
system size (atoms)
Maximum duration
of simulation (109 s)
1 No n/a 2328 4195 62,104 5.0
2 Yes n/a 2328 4199 62,187 5.0
3 No 40 pN 2328 or 2302 or 2252–2255 or 2278–2281 4195 330,468 5.0
4 Yes 40 pN 2328 4199 332,516 5.0
5 Yes 40 pN 2328 or 2302 or 2252–2255 or 2278–2281 4199 332,516 5.0
6 No 50 pN 2328 or 2302 or 2252–2255 or 2278–2281 4199 330,468 5.0
Model 1 served as the control, where no force or phosphorylation occurred, and confirms the crystallographic structure determined by Lad et al. (14). Model 2
included only physiological phosphorylation, and no force. Model 3 tests only the effect of force on this rod region. Model 4 and 5 test force and phosphor-
ylation together. Constraints are required when force is applied to this rod region to stabilize the integrin binding site. Model 6 illustrates that 50 pN of force
was needed to remove autoinhibition when phosphorylation is not present. n/a is defined as having no force applied.Biophysical Journal 97(12) 3095–3104
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mechanical force-induced activation of the integrin binding
of filamin-A are possible. However, how phosphorylation
or force can mechanistically accomplish this is unknown.
In this study, all combinations of phosphorylation and
tension total are tested, the absence of tension and phosphor-
ylation of Ser2152, our negative control, a phosphorylated
Ser2152 model without tension, an unphosphorylated Ser2152
model with tension, and a combination of phosphorylation
of Ser2152 and tension. As our simulations of these models
proceeded, it became necessary to include a fifth model to
further test and explore the effects of the loading conditions
imposed, and additional simulations with greater forces,
50 pN, and timescales, 5.0 ns, were also carried out. In the
following result descriptions, please keep in mind that the
force magnitudes quoted are used for relative comparisons
and may not necessarily reflect the magnitudes of force expe-
rienced by filamin-A under physiological conditions, i.e.,
they can be considerably smaller in vivo.
FIGURE 2 (A) Result of Model 4. FLNa-R21 was deformed due to only
fixing one amino acid in the C terminus. FLNa-R21 deformation was unde-
sirable and may be the reason why the b-inhibitor was not removed in this
case. The b-inhibitor was less likely to leave FLNa-R21 when FLNa-R21
was deformed. (B) An illustration of the positions of the multiple stabilizing
constraints on repeat 21. Of these 10 amino acids, four of them (2328, 2302,
2255, and 2278) are proline. By stabilizing these C-terminal loops of repeat
21, the structure was increasingly stable during tension and did not linearize
under tension (Fig. 3 A).Biophysical Journal 97(12) 3095–3104Model 1: without force and phosphorylation, the
autoinhibition cannot be removed
Model 1 was the negative control without phosphorylation or
applied force. The model was run with the complete IgFLNa-
R19–21 rod region. This simulation did not illustrate any
propensity of conformational change within 5 ns of simula-
tion run. The explicit solvent models also expressed no
conformational change. Six simulations all illustrate that the
crystallized structure of IgFLNa-R19–21 determined by Lad
et al. (14) was indeed a stable conformation at physiological
conditions in the absence of force and phosphorylation
(Fig. 1 C (A, red arrow)). In Model 1, the average RMSD
over the whole trajectory for 5 ns was 4.455 A˚, with a standard
deviation of 0.464 A˚. The RMSD value was consistent during
simulations at ~20 ps (Fig. S2).
Model 2: without force applied but with
phosphorylated Ser2152, the autoinhibition
still cannot be removed
Model 2 was a phosphorylated control that did not include
external force application. Surprisingly, the result was the
same as in Model 1; we had anticipated that phosphorylation
would alter the conformation of this region to affect autoinhi-
bition. Extending the simulation time beyond 500 ps to 5 ns
did not show any potential conformational changes due solely
to phosphorylation. Despite the increased ionic character with
the added phosphoryl group, our simulations with explicit
solvent models also confirmed the lack of a meaningful
conformational change (Fig. 1 B). This puts into question
whether or not activation can take place in the absence of
any physical forces.
In Model 2, the average RMSD over the whole trajectory
for 5 ns was 5.573 A˚, and the standard deviation was
0.237 A˚. The RMSD value does not fluctuate significantly
beyond the 40 ps timepoint (Fig. S2).
Model 3: without phosphorylation and pulled
under 40 pN, the autoinhibition began to
dissociate, yet complete removal cannot be
achieved
Model 3 was devised to test the effect of force only. In contrast
to Models 1 and 2, force can drastically alter the conformation
of the model (Fig. 3 A). The model was pulled for a total of
5 ns under 40 pN. After 100 ps of simulation, dissociation
of the b-strand inhibitor does not occur and the integrin
binding site fails to become exposed (Fig. 3 A). No further
conformational change takes place in the following time.
Furthermore, a shearing force is exhibited during the
b-strand’s association with the integrin binding site of
IgFLNa-R21. This can be visualized by the distortion in the
CD-face of IgFLNa-R21 (Fig. 3 A). Despite increasing the
force even beyond the typical 40 pN, the b-strand inhibitor
fails to dissociate before IgFLNa-R21 loses significant
Filamin and Integrin Binding 3099tertiary structure even with many stabilizing constraints
imposed. The intramolecular forces between the b-strand of
IgFLNa-R20 and IgFLNa-R21 can however tolerate ten-
sions >40 pN.
During initial simulations, force was applied parallel to the
axis of the rod domain, to result in pure tension without any
FIGURE 3 (A) Molecular trajectory of filamin-A rod domain repeats
19–21 under 40 pN of tension, Model 3, is illustrated. Multiple stabilizing
constraints were applied in this model. Each arrow represents ~100 ps. At
t1, or ~100 ps, the center of mass of repeat 19 (right) translates away to
move away from the center of mass of repeat 21 (middle). The gray bead
represents the harmonic constraint on repeat 21. Although torque and
tension is being applied to the b-strand inhibitor of IgFLNa-R20, the force
is not sufficient to result in complete dissociation of the b-strand inhibitor
and the integrin binding site of repeat 21. The autoinhibition remained
bound through the end of the simulation, t3, and even if the simulation pro-
ceeded to 1ns. (B) The filamin-A rod region 19–21 under tension with phos-
phoryl modification of Ser2152, Model 5, is illustrated here. The gray bead
represents the harmonic constraint on the C-terminus of the rod domain.
With the phosphorylation of Ser2152 residue, further dissociation from the
integrin binding site of the inhibitor is apparent within 100 ps. With 40 pN
and after 300 ps, the inhibition begins to further dissociate and translate
away from the integrin-binding site, and alternatively associates with repeat
20. Within 500 ps with 40 pN tension, the b-inhibitor can be removed
completely.resulting bending moment. However, tensile forces applied
parallel to the rod domain axis and b-strand inhibitor fail
to offer a component of force that will abduct the b-strand
inhibitor from IgFLNa-R21. This inevitably underlies the
observation that the b-strand inhibitor appears to shear the
CD-face of IgFLNa-R21, and fails to dissociate (Fig. 3 A).
This is a consequence of the inherent geometry and confor-
mation of the rod domain. We therefore hypothesized that
autoinhibition could be removed by pulling the bound
b-strand inhibitor from IgFLNa-R20 normal to the plane
containing the CD-face, exerting a torque in addition to
tension (Fig. 1 C (B, blue arrow)).
Whereas the application of torque leads to partial dissoci-
ation of the inhibitory b-strand (Fig. 3 A), the complete
dissociation could not be achieved due to IgFLNa-R21 loss
of tertiary structure under tension. Further partial removal
could be achieved through stabilizing constraints described
in Materials and Methods. We note the salt bridge between
Arg2146 and Asp2287 is significant enough to resist complete
dissociation of the autoinhibition. The result of this study
implied that bending of the rod domain is essential in the
removal of the autoinhibition in unphosphorylated models
(Fig. 3 A).
Model 4: IgFLNa-R21 unfolded into linear
sequence with only the C-terminus residue ﬁxed,
but the partial removal of autoinhibition may
suggest that the phosphorylation lowers the
constraint requirement
This model was first set to test the effect of phosphorylation
and external forces. Initially, we imposed no stabilizing
constraints for IgFLNa-R21. Although deformation of the
C-terminal domain of IgFLNa-R21 does occur with a 40 pN
tensile force, partial removal comparable to Model 3 could
be obtained with decreased magnitude of force as compared
to Model 3, e.g., with 30 pN (Fig. 3 A). Despite the deforma-
tion that occurs in the N-terminal domain of IgFLNa-R21 at
30 pN of tension force, the autoinhibitory b-strand can be
partially removed, but the association of Arg2146 with
Asp2287 seemed to be limiting. This removal is analogous to
the case in which a 40 pN force is applied as in Model 3,
and can result in partial removal of inhibition as illustrated
in Fig. 3A. Complete dissociation of the b-strand is prevented
by the ionic interaction between Arg2146 with Asp2287 as in
Model 3.
These results are surprising because partial removal could
not be accomplished in Model 3 without larger magnitude of
force and stabilizing constraints on IgFLNa-R21. This trans-
lates to a change in the requirements for the removal of the
inhibitory b-strand, and therefore the autoinhibition seemed
more likely to dissociate with phosphorylation present at
Ser2152.
Moreover, IgFLNa-R20 showed a tendency to refold at
100 ps with a 30 pN force applied, and despite autoinhibitionBiophysical Journal 97(12) 3095–3104
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appeared to rotate and position its anti-parallel b-strand
sandwich such that the inhibitory b-strand could position
and associate in an anti-parallel manner (Fig. 3A and Fig. 4B).
However, we note again that the destabilization of tertiary
structure of IgFLNa-R21 when subject to applied force is an
unrealistic and undesired phenomenon. Therefore, con-
straints were required to maintain the stability of IgFLNa-
R21, and were implemented in Model 5.
Model 5: with phosphorylation and applied 40 pN,
the autoinhibition was successfully removed
within 500 ps
Model 5 involved multiple constraints. Through trial and
error, the constraints were set as shown in Table 1. Residues
within the exposed loops near the C terminus of IgFLNa-R21
were harmonically constrained, and the number of
constraints was reduced to a minimum that could necessitate
maintenance of stability of IgFLNa-R21 during tension. All
of the fixed amino acids resided in IgFLNa-R21, and were
primarily proline residues, or adjacent to proline residues.
The fixed residues on IgFLNa-R21 are shown in Fig. 2 B.
Of the 10 fixed amino acids shown in Table 1, four of
them were prolines, namely residues 2328, 2302, 2255,
and 2278. The other six residues were all neighboring
prolines that helped to stabilize the proline turns.
Using these extra constraints was justifiable as prolines
are unique amino acid residues that often provide kinks and
turns in the tertiary structure of proteins. These proline resi-
dues provide the turns between the b-pleated sheets in all
repeats in filamin-A. Therefore, fixing these prolines stabi-
lizes IgFLNa-R21 by maintaining the tertiary structure of
IgFLNa-R21 and preventing the hydrogen bonds between
the b-pleated sheets from being disrupted by tension.
Although the model only includes IgFLNa-R19, -R20, and
-R21, it was suspected that IgFLNa-R22 or even further
repeats may provide stabilizing interaction with IgFLNa-
R21. In vivo, repeats IgFLNa-R22–24 may interact with the
proline residues and prevent IgFLNa-R21 from unfolding
on application of force. Unfortunately, this hypothesis cannot
be tested at this moment because IgFLNa-R19–21 is the most
complete elucidated crystal structure of filamin-A, and these
interactions should be probed if a structure becomes available.
Model 5 illustrates clear dissociation of the autoinhibition.
In the first 100 ps, similar to Model 3, the IgFLNa-R19 center
of mass begins to move away from the center of mass of
IgFLNa-R21. However in contrast to Model 3, at ~300 ps,
IgFLNa-R20 begins to rotate and orient itself in an antiparallel
fashion as it increases its proximity to the b-strand inhibitor.
At 350 ps, the autoinhibition completely dissociates from
IgFLNa-R21, and thus integrin binding is no longer sterically
hindered (Fig. 3 B) (see Movie S1). The dissociated b-strand
that was inhibiting the integrin binding of IgFLNa-R21 begins
to alternatively associate with its native tandem repeat,Biophysical Journal 97(12) 3095–3104IgFLNa-R20 (see Movie S1). This interaction seemed to
stabilize and hold the dissociated b-strand inhibitor in place,
and only occurs with phosphorylation.
In contrast to Model 3, pure tension without any torque is
sufficient to drive dissociation of the b-strand inhibitor. With
a 40 pN force, the direction of pulling appeared unimportant,
and all cases resulted in complete removal of auto inhibition
within 500 ps, analogous to the trajectory of Fig. 3 B.
An interesting observation was that the phosphorylated
Ser2152 residue laid within this non-b-pleated sheet amino
acid loop (Fig. S1). Moreover, this amino acid loop appeared
to have a strong tendency to fold toward the b-strand inhib-
itor in IgFLNa-R20. The simulation showed that during the
refolding of IgFLNa-R20, the loop and b-pleated sheet
migrate toward each other (see Movie S1). Taking a closer
look at the residues of the amino acid loop and the b-strand
inhibitor, there were four consecutive arginine residues
upstream of the inhibitor. The positively charged arginine
residues have relatively high affinity for the negatively
charged phosphate group on Ser2152.
Model 6: without phosphorylation, 50 pN is
required to remove autoinhibition
Model 6 was set out to test the minimum force required to
remove the autoinhibition in nonphosphorylated model.
The trajectory was similar to that of Model 5, which showed
complete removal of the autoinhibition within 100 ps.
Smaller forces applied to Model 3 and 5 did not
remove autoinhibition completely
Further simulations were carried out to test for the minimum
force required to remove the autoinhibition. Models pulled
with 10 pN and 20 pN did not propose appreciable confor-
mational changes in the protein. The center of mass of
IgFLNa-R19 did not translate away from IgFLNa-R21
(data not shown), and IgFLNa-R20 did not show any refold-
ing tendency. On the other hand, when 30 pN of tension is
applied, the distance of center of masses of IgFLNa-R19
and IgFLNa-R21 does increase, and IgFLNa-R20 began to
appear to refold, apparently rotating to position the bound
b-strand inhibitor into an anti-parallel b-strand topology,
all within 100 ps. A partial dissociation of the b-strand inhib-
itor, where Arg2146 remains bound, could be accomplished
within 400 ps with phosphorylation. However, extending
this 30 pN tension simulation to 5 ns did not illustrate that
a complete removal is possible with 30 pN(data not shown).
This test implies that a minimum force of 40 pN is required
to remove autoinhibition.
Explicit solvent models agreed with implicit
models
We tested Models 3–6 by running simulations that incorpo-
rated an explicit water box model to represent the solvent
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able to simulate, the trajectory was identical to the result in
our implicit model—the distance of the center of masses of
IgFLNa-R19 and IgFLNa-R21 increased with a 40 pN force,
the b-strand inhibitor began to dissociate similarly, and
IgFLNa-R20 appeared to associate with the previously
bound b-strand inhibitor. The molecular trajectories in both
explicit and implicit models were analogous in both phos-
phorylated and nonphosphorylated models.
DISCUSSIONS
The integrin binding activation of filamin-A is hypothesized
to occur through three potential mechanisms, by phosphory-
lation at Ser2152, mechanical force, or alternative splicing
generated isoforms of filamin-A. Although alternative
splicing is not tested in this study, our results can shed light
on two of the three current hypotheses leading to filamin-A
integrin binding activation. Activation of filamin-A’s integrin
binding capacity is evaluated by determining if autoinhibition
is disrupted and the integrin binding site of IgFLNa-R21 is
exposed. Testing the combined effects of tension on
IgFLNa-R19-21 and phosphorylation revealed that phosphor-
ylation of Ser2152 without tension is not sufficient to result in
activation. However, by increasing the applied force, the
b-strand inhibitor from IgFLNa-R21 without phosphoryla-
tion can be removed. The results suggest that the phosphory-
lation is there to decrease the requirement, and thus increase
the chance, to remove the autoinhibition. Removal of autoin-
hibition can still be achieved without phosphorylation. Phys-
iologically, integrin binding of filamin-A may be activated
after being phosphorylated at Ser2152 and when subsequent
tension is applied to the rod domain.
Phosphorylation was also shown to lower the constraints
requirements, magnitude of force (or torque) required for
complete removal of the b-strand inhibition of IgFLNa-
R21. This conclusion was derived by comparing the trajectory
events in Models 2–6. Models 1–3 are controls. Model 1 was
not phosphorylated and no force was applied. Model 2 was
phosphorylated but not pulled, whereas Model 3 was pulled
but not phosphorylated.
The results of Model 1 and 2 were interesting and unex-
pected. Without any applied pulling force, the structure
showed no meaningful conformational changes. In a previous
work by Lad et al. (14), mechanical force had been proposed
as a possible regulatory mechanism for the promotion of fil-
amin-A integrin binding. In addition, phosphorylation was
also listed as a possible method to elicit filamin-A integrin
binding, but is insufficient in modulating integrin binding
activity in experiments (42). In our phosphorylation simula-
tions, however, we found by comparing Models 2 and 1,
where Model 2 was phosphorylated, and Model 1 unphos-
phorylated, that the results were identical. Neither model
illustrated a tendency to dissociate the autoinhibition present
on IgFLNa-R21. On the other hand, simulating force on anunphosphorylated IgFLNa-R19-R21, Model 3, autoinhibi-
tion could at least partially be removed with higher forces
and with maximum torque, i.e., perpendicularly to the rod
domain axis. We note that this event in Model 3 does require
stabilization of IgFLNa-R21. Complete removal in a non-
phosphorylated model requires more applied force than its
phosphorylated counterpart.
Although Model 1 and 2 suggest that the integrin inhibi-
tory strand does not dissociate from filamin-A without
applied force, other experiments (42) support that filamin-
A binds with integrins isolated from cell lysates, where there
is assumed to be no applied force. To address this problem,
we re-equilibrated Model 3 and 4 for 3 ns. After the integrin-
binding site is exposed and tension removed, we observed
no potential to refold. Thus, we hypothesize that the fila-
min-A was activated previously by force before the cell was
lysed.
The geometry of the complex formed by b-strand inhibitor
and IgFLNa-R21 CD face underlies why an absolute absence
of torque cannot sufficiently accomplish removal of the auto-
inhibition. To drive dissociation of the b-strand inhibitor,
a torque must be supplied. The b-strand inhibition sits within
a groove formed on the CD face of IgFLNa-R21 by two anti-
parallel b-strands of this same repeat (Fig. 1 B). Pure tension
simply results in a shear stress on the face of this groove and
only serves to further destabilize the tertiary structure of
IgFLNa-R21. An effective torque applies a component of
force that serves to displace the b-strand from the binding
site. Thus, the logical way to remove the inhibitor was to pull
it away, in a direction perpendicular to and outward of the
plane containing the three interacting b-strands (Fig. 1 C).
We noted, however, that pure tension can result in dissocia-
tion of the b-strand when the rod region IgFLNa-R19-21 is
phosphorylated at Ser2152. This may be accomplished by
the phosphoserine attraction with Arg2146–2149. These strong
interactions on the b-strand inhibitor may provide sufficient
torque to allow removal of the b-strand inhibitor from the
integrin binding site of IgFLNa-R21 during tension.
Phosphorylation increases effectively the sensitivity of
removal of the autoinhibition of IgFLNa-R19–21 to loading
conditions. Furthermore, the magnitude of tension could be
reduced to result in filamin-A activation of integrin binding.
Although phosphorylation of the Ser2152 residue lowers the
threshold of tensile force required to remove the autoinhibi-
tion, we found that mechanical force was necessary to
remove the autoinhibition and reveal the binding site for
integrin. In other words, phosphorylation of Ser2152 without
force is not sufficient to result in removal of the autoinhibi-
tion on IgFLNa-R21.
In the experiment by Travis et al. (42), phospho-blocking
or mimicking mutations did not interfere with the ability of
integrin-binding in cell lysate. This finding in light of our
results, leads one to propose that the function of phosphory-
lation on Ser2152 is kinetic rather than thermodynamic. Phos-
phorylation reduces the force and constraints requirements,Biophysical Journal 97(12) 3095–3104
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causes the integrin binding reaction to proceed quicker.
However, with sufficient force and time, the autoinhibition
will eventually be removed. In the experiment by Travis
et al. (42), the cells remain intact for 48 h before they are
lysed, and this may sufficiently activate a detectable popula-
tion of filamin-A molecules.
We also speculated that applied tensile forces would lead to
the refolding of IgFLNa-R20, and assist in the removal of
autoinhibition, but could only find evidence for refolding
of IgFLNa-R20 in phosphorylated models with tension
(Models 4 and 5). In these models, the amino acid loop
that contained phosphoSer2152 in IgFLNa-R20 (Fig. S1)
approaches the b-strand inhibitor and associates with
Arg2146–2149 on the inhibitor. Furthermore, association with
IgFLNa-R20 can stabilize the b-strand inhibition and the
energetic costs of dissociation from IgFLNa-R21 may be
compensated by this phenomenon. This interaction may serve
to further promote integrin binding on IgFLNa-R21 by
keeping the dissociated competitive inhibitor away from its
binding site. The conformational changes discussed in this
study may mechanistically describe activation of filamin-
A’s integrin binding in vivo. However, future studies should
actually assess whether forced dissociation of the inhibitory
b-strand of IgFLNa-R20 is sufficient to lead to filamin-A
binding to integrin in vivo.
The stability of IgFLNa-R21 was also a significant factor
in our analysis and in determining if integrin binding is
possible once the autoinhibition has been removed. We
hypothesize that the stabilizing constraints possibly represent
downstream repeats, IgFLNa-R22–24, that may interact with
IgFLNa-R21. Empirically we found 10 amino acids that
were key for stability of IgFLNa-R21, four proline residues,
and the remaining six being neighbors of these and other
proline residues (Fig. 2 B). These proline residues provided
turns and loops in the Ig-like fold and had a major role in
maintaining the tertiary structure of IgFLNa-R21. However,
this hypothesis cannot be tested with our current methods as
no crystallized model, including IgFLNa-R21 and IgFLNa-
R22 for example, is available currently (2,14,37).
Alternatively, these interactions may be required for
the timescales under which we implemented our analysis.
A decreased force magnitude may be sufficient to remove
autoinhibition if this occurred over the relatively much longer
duration of a microsecond. Eventually, the time dependence
in these trajectories may be assessed in the future as increased
computational power becomes available to allow for much
longer scale simulations (43). We expect that the responses
described herein may have considerably decreased stress
thresholds in vivo and this should be investigated through
simulating smaller forces on the rod region over much greater
timescales.
Comparison between Model 3 and 5 illustrates the
dramatic effect phosphorylation of Ser2152 may have on
stability of the b-strand inhibitor. Between these two models,Biophysical Journal 97(12) 3095–3104all variables were held constant with the exception of the
phosphoryl modification of Ser2152 for Model 5 versus
Model 3 where the structure was simulated without phos-
phorylation. Without phosphorylation, a minimum of 40 pN
of tensile force was required to result in only partial removal
of the b-strand inhibitor, but many stabilizing constraints
must be imposed and the tension must induce significant tor-
que. Nevertheless, autoinhibition could be destabilized and
nearly disabled with forces as small as 30 pN extension
forces with phosphorylation of Ser2152, but a 40 pN force
most reliably and quickly removed inhibition completely.
This result strongly suggested that the phosphate group
effectively decreased the requirement to remove the autoin-
hibition, and facilitates integrin binding, which could lead
to a mechanotransduction event.
Phosphorylation on Ser2152 increases the affinity of this
now modified, negatively charged residue to ionically
interact with the positively charged arginine residues on
the b-strand inhibitor, Arg2146–2149 (Fig. S1). We find this
phosphoserine binds to and stabilizes the b-inhibitor once
it dissociates from the binding site. The salt bridges formed
between phosphoSer2152 and the Arg2146–2149 may stabilize
the unbound b-strand facilitating its removal. Therefore,
without phosphorylation of Ser2152, higher tensile forces
were required to remove the b-inhibitor.
Although our results showed that 40 pN was the minimum
force required to remove the b-inhibitor, again we consider
that in vivo over much longer timescales, less force may
be required. To save computation time, we typically pulled
the protein for 500 ps, which is relatively short as most bio-
logical reactions take place in a timescale of microseconds
(44,45). If the model was pulled for longer time, the required
force could decrease, but our multiple short simulations are
statistically relevant (46).
The results from the models are consistent with the
hypothesis that phosphorylation of Ser2152 decreases the
loading constraints required to remove autoinhibition. Func-
tionally, from these data we hypothesize phosphorylation of
Ser2152 increases the sensitivity of the rod region IgFLNa-
R19–21 to tensile forces. If phosphorylation serves to lower
the tension threshold required to remove autoinhibition of fil-
amin-A binding to integrin, then cell sensitivity to stress can
be modulated. Therefore, phosphorylation of filamin-A can
play an interesting dual role in the mechanosensitivity of
the cell. Conversely, previous experiments by Shifrin et al.
(23) and Glogauer et al. (24) have shown that filamin-A is
necessary to modulate cellular desensitization to force.
Filamin-A may mediate cell survival during mechanical
stress via dephosphorylation and therefore decreasing cell
sensitivity to force (23,24). However, the possibility remains
that in vivo filamin-A may solely function in its phosphory-
lated form, and that both tension and phosphorylation are
required for physiological activity.
Furthermore, because mechanical force is involved in the
promotion of integrin binding, filamin-A may have a
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pathway. Although a recently published structure illustrating
that the other two rod regions resembling IgFLN-aR20–21,
IgFLNa-R16–17, and IgFLNa-R18–19, lack phosphorylation
regulatory sites, mechanical force may alter the observed
packed domain arrangements (47). Mechanical stimulation
may facilitate multiple conformational changes in the rod
domain. For instance, many in vivo and in vitro observations
demonstrate the propensity of cells to form focal adhesions
with mechanical stimuli (6,25,48,49). Filamin-A may be
involved in the formation of focal adhesions from the matura-
tion of focal complexes (8). Because the cortical actin network
is under tension due to myosin-II activity, filamin-A can be
activated once localized in the cortical network and therefore
bind to integrin (22).
CONCLUSION
The simulations in this study suggest that mechanical force
may be a major and direct cause of autoinhibition removal.
Phosphorylation on Ser2152 increases the possibility of
removal by decreasing the force and constraints requirement.
However, the proline constraints used in the simulation
models are obtained through trial and error. Although we
provide many hypothetical explanations and justifications,
further investigations are indeed desired, especially the inter-
action between IgFLNa-R21 and IgFLNa-R22–R24 that
helps the stabilization of the model.
Future experiments should also consider identifying if
cells indeed can modulate their mechanosensitivity via
filamin-A phosphorylation. We are currently working to
include a more complete molecular picture of cellular me-
chanotransduction, and hope to include future simulations
of structures with more filamin-A repeats, filamin homologs
and other actin-binding proteins. In addition, in vitro AFM
experiments with filamin-A can serve as a great comparison
with the molecular conformations proposed here. These
experiments may be beneficial in supporting a clearer picture
of cellular mechanotransduction.
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